Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine
Clinical trial NCT05846230 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05846230
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-08
- Primary completion
- 2027-03-31
- Enrollment
- 268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.